A photo of Meilan Rutter.

Medical Director, Differences/Disorders of Sex Development (DSD) Center

Assistant Director, Pediatric Endocrinology Fellowship Training Program

Associate Professor, UC Department of Pediatrics

513-636-4744

513-636-7486

Board Certified

Best Doctors logo

My Biography & Research

Biography

Meilan Rutter is board-certified in pediatric endocrinology, and has been on the faculty of Cincinnati Children’s Hospital Medical Center and the University of Cincinnati since 2008. She completed her training in the United Kingdom, New Zealand and Cincinnati. She serves as the medical director of the Cincinnati Children’s Differences/Disorders of Sex Development (DSD) Center and the assistant director of the pediatric endocrinology fellowship training program.

Dr. Rutter cares for children and adolescents with a wide spectrum of endocrine conditions, including growth, puberty, thyroid and adrenal disorders. She collaborates with interdisciplinary specialists to deliver the endocrine aspects of comprehensive and integrated care for patients with complex conditions. She leads the Cincinnati Children’s DSD Center, which provides interdisciplinary care for people born with conditions affecting reproductive development. The DSD Center is a member of the DSD-Translational Research Network, a national network that strives to optimize and standardize clinical practices and advance scientific knowledge in this field. Dr. Rutter also serves as the primary endocrine consultant for the Cincinnati Comprehensive Neuromuscular Center. In conjunction with the neuromuscular team, she has helped pioneer global awareness of the importance of endocrine issues in patients affected by Duchenne Muscular Dystrophy.

Additional Languages

French, Mandarin

Clinical Interests

Pediatric endocrinology, including growth, puberty, thyroid and adrenal disorders; differences / disorders of sex development, or conditions affecting reproductive development; endocrine and bone health in neuromuscular conditions

Research Interests

Differences / disorders of sex development; endocrine issues and bone health associated with Duchenne muscular dystrophy

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Departments

Endocrinology, Fanconi Anemia, Leukemia, Neuromuscular Disorders, Diabetes, 22Q-VCFS, Disorders of Sex Development, Sturge-Weber Syndrome, Endocrinology

My Locations

My Education

MB, BCh: University of Wales College of Medicine, Cardiff, United Kingdom.

FRACP: Royal Australasian College of Physicians, New Zealand.

Residency: University Hospital of Wales, Cardiff, United Kingdom; Auckland Children's Hospital, Auckland, and Dunedin Hospital, Dunedin, New Zealand; Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Fellowship: Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Certification: American Subspecialty Board of Pediatric Endocrinology, 2003, recertified 2013; American Board of Pediatrics, 2002; Fellow of the Royal Australasian College of Physicians (Pediatrics), 1995.

My Publications

Central Diabetes Insipidus in a Patient With NFKB2 Mutation: Expanding the Endocrine Phenotype in DAVID Syndrome. Nasomyont, N; Lindsley, AW; Assa'ad, A; Dawson, DB; Neilson, DE; Brady, CC; Rutter, MM. Journal of Clinical Endocrinology and Metabolism. 2019; 104:4051-4057.

Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naive Patients with Duchenne Muscular Dystrophy. Sawnani, H; Horn, PS; Wong, B; Darmahkasih, A; Rybalsky, I; Shellenbarger, KC; Tian, C; Rutter, MM; Simakajornboon, N; Amin, R; et al. The Journal of Pediatrics. 2019; 210:194-200.e2.

Psychosocial Screening in Disorders/Differences of Sex Development: Psychometric Evaluation of the Psychosocial Assessment Tool. Ernst, MM; Gardner, M; Mara, CA; Delot, EC; Fechner, PY; Fox, M; Rutter, MM; Speiser, PW; Vilain, E; Weidler, EM; et al. Hormone Research in Paediatrics: from developmental endocrinology to clinical research. 2019; 90:368-380.

Homozygous Calcium-Sensing Receptor Polymorphism R544Q Presents as Hypocalcemic Hypoparathyroidism. Cavaco, BM; Canaff, L; Nolin-Lapalme, A; Vieira, M; Silva, TN; Saramago, A; Domingues, R; Rutter, MM; Hudon, J; Gleason, JL; et al. Journal of Clinical Endocrinology and Metabolism. 2018; 103:2879-2888.

Endocrine disorders. Giri, N; Hollenberg, T; Lodish, M; Petryk, A; Rose, SR; Rutter, MM; Kanakatti Shankar, R; Stratakis, CA. In: Stratakis C, Ed. Fanconi Anemia: Guidelines for Diagnosis and Management. Eugene, Oregon: Fanconi Anemia Research Fund, Inc.; 2018.

Global Application of the Assessment of Communication Skills of Paediatric Endocrinology Fellows in the Management of Differences in Sex Development Using the ESPE E-Learning.Org Portal. Kranenburg, LJ C; Reerds, ST H; Cools, M; Alderson, J; Muscarella, M; Magrite, E; Kuiper, M; Abdelgaffar, S; Balsamo, A; Brauner, R; et al. Hormone Research in Paediatrics: from developmental endocrinology to clinical research. 2017; 88:127-139.

Low bone mineral density and fractures are highly prevalent in pediatric patients with spinal muscular atrophy regardless of disease severity. Wasserman, HM; Hornung, LN; Stenger, PJ; Rutter, MM; Wong, BL; Rybalsky, I; Khoury, JC; Kalkwarf, HJ. Neuromuscular Disorders. 2017; 27:331-337.

Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment. Wong, BL; Rybalsky, I; Shellenbarger, KC; Tian, C; McMahon, MA; Rutter, MM; Sawnani, H; Jefferies, JL. The Journal of Pediatrics. 2017; 182:296-303.e1.

Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy. Tian, C; Wong, BL; Hornung, L; Khoury, JC; Miller, L; Bange, J; Rybalsky, I; Rutter, MM. Neuromuscular Disorders. 2016; 26:760-767.

Late endocrine effects of childhood cancer. Rose, SR; Horne, VE; Howell, J; Lawson, SA; Rutter, MM; Trotman, GE; Corathers, SD. Nature Reviews Endocrinology. 2016; 12:319-336.